AGAPE ATP CORPORATION Deferred Costs, Noncurrent
AGAPE ATP CORPORATION (ATPC) had Deferred Costs, Noncurrent of $613.11 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredCosts · last filed 2024-04-01
- 2023-09-30: Deferred Costs, Noncurrent $613.11K.
- 2023-06-30: Deferred Costs, Noncurrent $522.06K.
- 2023-03-31: Deferred Costs, Noncurrent $506.16K.
- 2022-12-31: Deferred Costs, Noncurrent $499.20K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2023-09-30 | $613.11K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $522.06K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $506.16K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $499.20K 10-K · filed 2024-04-01 |
| 2022-09-30 | $449.20K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $443.66K 10-Q · filed 2022-08-11 |
| 2021-12-31 | $264.74K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |